Journal of Advanced Research, 2026
Integrating clinical, proteomics, and polygenic scores to improve cardiovascular risk prediction: a prospective cohort study

Ding Y., Hong G., Wang Z. et al.

Gut Microbes, 2026
Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression

Vaaben T., Lützhøft D., Hedin K. et al.

Frontiers in Immunology, 2026
TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis

Evangelista J., Nisperuza Vidal A., Xu D. et al.

Aging Cell, 2026
Bidirectional Relationship and Shared Mechanisms Between Sarcopenia and Osteoporosis: An Observational Study Integrating Genomic, Proteomic, and Metabolomic Data

Xu S., Wen S., Zong X. et al.

The Journal of Nutrition, 2026
Oat-Rich Low-Gluten Diet Modulates Plasma Short-Chain Fatty Acids without Significant Changes in Fecal Microbiome or Inflammatory Markers—A Randomized Clinical Trial in People with Cardiometabolic Risk

Mannila E., Gómez-Gallego C., Muluh G. et al.

Journal of Clinical Investigation, 2026
Rheumatoid factor production is genetically and molecularly distinct from rheumatoid arthritis

Hocaoglu M., Sawalha A.

Inflammation Research, 2026
Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury

Van Nynatten L., Tweddell D., Daley M. et al.

International Journal of Molecular Sciences, 2026
APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis

Dźwigała M., Sys D., Życka-Krzesińska J. et al.

Journal of Inflammation Research, 2026
Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema

Yu T., Li S., Cheng F. et al.

Psychotherapy and Psychosomatics, 2026
Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways

Wei W., Cheng B., He D. et al.

Journal of Cardiovascular Translational Research, 2026
The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling

Los J., Mensink F., Bulut ?. et al.

Scientific Reports, 2026
Plasma COL3A1 propeptide as a promising prognostic marker in oral squamous cell carcinoma

Magan M., Gu X., Sgaramella N. et al.

Hepatology International, 2026
Pathological transcriptional retention of Cyp26b1 in perirenal adipose-derived stem cells contributes to MASLD progression

Zhang Y., Li Z., Sun J. et al.

Biomedicines, 2026
Integrative Multi-Omics Profiling of Dynamic Body Mass Index–Systolic Blood Pressure Trajectories in Obesity for Precision Risk Stratification of Heart Failure Subtypes

Zhai Y., Ma Q., Zhang X. et al.

Frontiers in Nephrology, 2026
Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank

Jiang L., Li T., Zhang H. et al.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2026
Baseline inflammatory profiles in moderate-to-severe depression and differential response to intermittent theta-burst stimulation

Pedraz-Petrozzi B., Wilkening J., Ziegler N. et al.

Journal of the European Academy of Dermatology and Venereology, 2026
Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages

Francke L., Al‐Bayatti A., Zhang H. et al.

International Journal of Biological Macromolecules, 2026
FES suppresses macrophage-mediated inflammation and atherosclerotic plaque formation by modulating the PU.1/Arg1 axis

He M., Liu X., Xu Z. et al.

eBioMedicine, 2026
Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity

Bhandage A., Stascheit F., Preßler H. et al.

Stem Cell Research & Therapy, 2026
Endothelial–immune cells-on-chip for multiplex evaluation of drug responses through patient plasma screening

Lee K., Wee H., Teng Z. et al.